Chemours Co. (CC) intrinsic value & 10-year financials
Chemours Co. (CC) has a Graham intrinsic value of $4.98 per share. At $12.62 on Oct 20, 2026, the stock trades 153% above that value. Over the last 10 fiscal years revenue grew 0.8% a year to $5.8B, with an average return on invested capital of 7.5%.
- Graham intrinsic value
- $4.98
- Share price (Oct 20, 2026)
- $12.62
- Price vs Graham value
- 153% above
- Market cap
- $1.9B
- Revenue (FY2025)
- $5.8B
- Revenue growth (10-yr CAGR)
- 0.8%
- ROIC (10-yr avg)
- 7.5%
- Free cash flow (FY2025)
- $51.0M
CC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $5.8B | -$386.0M | -$2.57 | $51.0M | — | -9.9% |
| FY2024 | $5.8B | $86.0M | $0.57 | -$993.0M | — | 2.2% |
| FY2023 | $6.0B | -$238.0M | -$1.60 | $186.0M | — | -6.5% |
| FY2022 | $6.8B | $578.0M | $3.65 | $447.0M | — | 16.3% |
| FY2021 | $6.3B | $608.0M | $3.60 | $543.0M | — | 16.9% |
| FY2020 | $5.0B | $219.0M | $1.32 | $540.0M | — | 5.7% |
| FY2019 | $5.5B | -$52.0M | -$0.32 | $169.0M | — | -1.3% |
| FY2018 | $6.6B | $995.0M | $5.45 | $642.0M | — | 27.3% |
| FY2017 | $6.2B | $746.0M | $3.91 | $228.0M | — | 23.9% |
| FY2016 | $5.4B | $7.0M | $0.04 | $256.0M | — | 0.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Chemours Co has demonstrated mature, steady growth, with revenue compounding at 0.8% annually over the past decade.
Chemours Co has historically struggled to out-earn its cost of capital, averaging just 7.5% ROIC.
Over the decade, Chemours Co shows that management has aggressively returned capital to shareholders by retiring 18.1% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Chemours Co is modeled at 0.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $4.98 per share.